LeadIQ logo
Learn more at LeadIQ.com

Insights

Key Client Acquisition Exothera recently secured a contract with the National Institutes of Health (NIH) to develop the manufacturing process for their intranasal COVID-19 vaccine. This collaboration presents a significant opportunity for partnership with prestigious organizations in the health sector.

Technology Partnership Exothera partnered with Quantoom Biosciences to leverage their Nfinity technology for continuous RNA production. This strategic alliance demonstrates Exothera's commitment to cutting-edge technologies and opens doors for collaboration with innovative biotech companies.

Expansion into RNA Therapies Market With the appointment of Dr. Patrick Thiaville as Chief Technology Officer, Exothera Nucleic Acids aims to expand its presence in the rapidly growing RNA therapies market. This leadership addition signals potential for exploring new avenues in personalized medicine and drug development.

Collaboration with Biotechnology Startups Exothera's partnership with Meissa Vaccines to provide manufacturing services for viral respiratory infection vaccines signifies an opportunity to collaborate with emerging biotech startups. This collaboration showcases Exothera's expertise in supporting innovative vaccine development initiatives.

Clinical Material Development Through a collaboration with Vaccizone, Exothera is utilizing its scale-X technology to produce clinical material for Vaccizone’s COVID-19 vaccine. This project presents a strategic opportunity to engage with companies in the pharmaceutical sector seeking advanced manufacturing solutions for vaccine development.

Similar companies to Exothera

Exothera Tech Stack

Exothera uses 8 technology products and services including NitroPack, Odoo, Mailchimp, and more. Explore Exothera 's tech stack below.

  • NitroPack
    Caching
  • Odoo
    Content Management System
  • Mailchimp
    Email
  • Google Font API
    Font Scripts
  • Google Cloud
    Infrastructure As A Service
  • Open Graph
    Miscellaneous
  • .NET
    Programming Languages
  • Python
    Programming Languages

Media & News

Exothera 's Email Address Formats

Exothera uses at least 1 format(s):
Exothera Email FormatsExamplePercentage
F.Last@exothera.worldJ.Doe@exothera.world
49%
First@exothera.worldJohn@exothera.world
1%
F.Last@exothera.worldJ.Doe@exothera.world
49%
First@exothera.worldJohn@exothera.world
1%

Frequently Asked Questions

Where is Exothera 's headquarters located?

Minus sign iconPlus sign icon
Exothera 's main headquarters is located at Allée Centrale de Jumet 52 Jumet, 6040 BE. The company has employees across 3 continents, including EuropeNorth AmericaAsia.

What is Exothera 's official website and social media links?

Minus sign iconPlus sign icon
Exothera 's official website is exothera.world and has social profiles on LinkedIn.

How much revenue does Exothera generate?

Minus sign iconPlus sign icon
As of July 2024, Exothera 's annual revenue reached $35M.

What is Exothera 's SIC code NAICS code?

Minus sign iconPlus sign icon
Exothera 's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Exothera have currently?

Minus sign iconPlus sign icon
As of July 2024, Exothera has approximately 201 employees across 3 continents, including EuropeNorth AmericaAsia. Key team members include Chief Technology Officer: H. P. L.Chief Operating Officer: C. B.Head Of Development: V. M.. Explore Exothera 's employee directory with LeadIQ.

What industry does Exothera belong to?

Minus sign iconPlus sign icon
Exothera operates in the Biotechnology Research industry.

What technology does Exothera use?

Minus sign iconPlus sign icon
Exothera 's tech stack includes NitroPackOdooMailchimpGoogle Font APIGoogle CloudOpen Graph.NETPython.

What is Exothera 's email format?

Minus sign iconPlus sign icon
Exothera 's email format typically follows the pattern of . Find more Exothera email formats with LeadIQ.
Exothera

Exothera

Biotechnology ResearchJumet, Belgium201-500 Employees

Exothera is a contract research, development, and manufacturing organization (CDMO) dedicated to viral vector and nucleic acids production. As a technology-driven company, Exothera provides best-in-class bioprocessing expertise that capitalizes on the best and most innovative manufacturing technologies developed within the Univercells group. The company delivers accelerated discovery services as well as process development/optimization to rapidly reach GMP clinical and commercial production of viral vectors and nucleic acids. At Exothera and Univercells, Our mission is to make life-changing therapies available to all.

As a Univercells company, Exothera capitalizes on novel manufacturing technologies and best-in-class bioprocessing expertise to provide custom-made process optimization and GMP clinical and commercial production of viral vectors. Based on its extensive technology expertise, Exothera selects technologies to optimally answer customer needs for cost-effective and agile viral vector manufacturing.

Company number: 0744643660 
VAT: BE0744643660 

Section iconCompany Overview

Headquarters
Allée Centrale de Jumet 52 Jumet, 6040 BE
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
201-500

Section iconFunding & Financials

  • $10M$50M

    Exothera 's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $10M$50M

    Exothera 's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.